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Abstract
Pulmonary infections are a major global cause of morbidity, exacerbated by an increasing
threat from antibiotic-resistant pathogens. In this context, therapeutic interventions aimed at
protectively modulating host responses, to enhance defence against infection, take on ever
greater significance. Pseudomonas aeruginosa is an important multidrug-resistant, opportu-
nistic respiratory pathogen, the clearance of which can be enhanced in vivo by the innate
immune modulatory properties of antimicrobial host defence peptides from the cathelicidin
family, including human LL-37. Initially described primarily as bactericidal agents, cathelici-
dins are now recognised as multifunctional antimicrobial immunomodulators, modifying host
responses to pathogens, but the key mechanisms involved in these protective functions are
not yet defined. We demonstrate that P. aeruginosa infection of airway epithelial cells pro-
motes extensive infected cell internalisation of LL-37, in a manner that is dependent upon
epithelial cell interaction with live bacteria, but does not require bacterial Type 3 Secretion
System (T3SS). Internalised LL-37 acts as a second signal to induce inflammasome activa-
tion in airway epithelial cells, which, in contrast to myeloid cells, are relatively unresponsive
to P. aeruginosa. We demonstrate that this is mechanistically dependent upon cathepsin B
release, and NLRP3-dependent activation of caspase 1. These result in LL-37-mediated
release of IL-1β and IL-18 in a manner that is synergistic with P. aeruginosa infection, and
can induce caspase 1-dependent death of infected epithelial cells, and promote neutrophil
chemotaxis. We propose that cathelicidin can therefore act as a second signal, required by
P. aeruginosa infected epithelial cells to promote an inflammasome-mediated altruistic cell
death of infection-compromised epithelial cells and act as a “fire alarm” to enhance rapid
escalation of protective inflammatory responses to an uncontrolled infection. Understanding
this novel modulatory role for cathelicidins, has the potential to inform development of novel
therapeutic strategies to antibiotic-resistant pathogens, harnessing innate immunity as a
complementation or alternative to current interventions.
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Author summary
Lung infections are a common cause of death worldwide. As the threat of antibiotic-resis-
tance becomes realised, new approaches are needed to treat disease-causing bacteria, such
as multidrug-resistant Pseudomonas aeruginosa. Treatments that could enhance the
body’s most effective natural defences can overcome antibiotic-resistance issues and/or
complement existing therapies. Antimicrobial Host Defense Peptides, such as human LL-
37, can kill microbes, but also have vital roles in clearing lung infections by modifying nat-
urally-occurring defenses. Understanding these “immunomodulatory” activities is key to
harnessing their potential. Airway lining cells have important barrier roles, but, if infected,
these compromised cells must be removed and signal danger, to prevent harmful bacteria
establishing a protected site and proliferating. We show that when Pseudomonas aerugi-
nosa infects these cells, LL-37 can provide a second signal, acting like a fire alarm, instruct-
ing the compromised cells to signal the danger, to recruit host defence cells to the site, and
to activate their own altruistic death. We demonstrate the mechanism of this process,
from bacterial and host cell perspectives, occurring by activation of an intracellular sens-
ing platform (the NLRP3 inflammasome) with a novel synergy between the infection and
the impact of LL-37, with implications for innovative new approaches to treat multi-drug
resistant infections.
Introduction
Pulmonary diseases caused by bacterial or viral infections are a common cause of morbidity
and account for 1 in 5 deaths in the UK [1]. There is an increasing global threat from antibi-
otic-resistant bacterial infections and newly emerging viral infections. In this context, thera-
peutic interventions aimed at protectively modulating host responses, to enhance defence
against infection, take on greater significance as alternative or complementary future
approaches. An important component of first line defences against such infections is the
innate immune response of airway epithelial cells, which constitute the principal barrier first
encountered by respiratory pathogens. These innate epithelial cell responses include the secre-
tion of antimicrobial host defence peptides (HDP) [2, 3], and the release of chemokines and
cytokines to help orchestrate the response of other immune effector cells. HDP are produced
by innate immune effector cells in response to infection, damage and inflammation [4] Under-
standing their effect on epithelial cell responses to infection is important in elucidating the
potential of HDP as targets for development of future antimicrobial interventions.
HDP are evolutionarily conserved short cationic peptides with direct and indirect antimi-
crobial activity, produced by a wide range of cells, including neutrophils, macrophages and
epithelial cells. In addition to their well-characterised microbicidal activity against bacteria,
viruses and fungi [4, 5], HDP can have a wide range of immunomodulatory and inflammomo-
dulatory properties [4, 6]. The cathelicidin family of HDP, including the sole human cathelici-
din LL-37/h-CAP18, has a particularly broad range of modulatory properties and has been
shown to be critical to host defence against infections in vivo in a wide range of systems [7],
including bacterial and viral pulmonary infections [8–10]. Cathelicidin can promote clearance
of bacterial lung infection in vivo specifically by inflammomodulatory mechanisms, in the
absence of susceptibility of the pathogen to direct peptide-mediated killing [8]. However, the
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mechanisms employed to alter the nature and/or efficacy of host responses to bacterial lung
infection in vivo remain unclear. HDP, including cathelicidin, have been shown to modulate
innate pattern recognition receptor (PRR) responses in host cells, including airway epithelial
cells [11–13]. This raises the possibility that HDP-mediated changes to the earliest responses
after epithelial cell detection of infection could dramatically alter the effectiveness of the early
host defence and outcome of infection.
PRRs can function extra- and intracellularly, and include Toll-like Receptors (TLR), NOD-
like receptor (NLR), C-type lectin receptors and RIG-I receptors [14, 15]. These receptors can
recognise highly conserved pathogen associated molecular patterns (PAMPs) to initiate innate
responses to infectious non-self threats, and are critical to effective host defence against infec-
tion. In addition to their capacity to modulate TLR signaling, cathelicidins have also been sug-
gested to activate inflammasomes [16, 17]; cytoplasmic multi-protein sensing platforms
formed by some NLRs to respond to PAMPs [18]. Inflammasome activation can lead to activa-
tion of the cysteine protease caspase 1, processing and release of pro-inflammatory cytokines
IL-1β and IL-18, and causing a pro-inflammatory form of cell death, termed “pyroptosis” in
macrophages. These responses would be expected to promote an inflammatory response, but
their significance in airway epithelial cells is not well understood.
Mechanisms that promote an early and/or enhanced inflammatory response to infection
have the potential to stimulate early pathogen clearance and resolution, when appropriately
regulated. Our previous studies demonstrated that cathelicidin, whether infection-induced
endogenous peptide, or early therapeutically administered peptide, promoted murine pulmo-
nary clearance of Pseudomonas aeruginosa [8]. This was the result of cathelicidin-mediated
upregulation of early neutrophil recruitment and generation of an enhanced pro-inflamma-
tory response to infection. However, the mechanisms underlying initiation of enhanced
inflammomodulatory clearance of this multi-resistant, opportunistic respiratory pathogen
remained unknown. We have also demonstrated that cathelicidin modified airway epithelial
cell responses to P. aeruginosa by inducing cell death of infected cells [19], potentially remov-
ing a safe niche for these pathogens in the lung. Here we focus on determining the mechanisms
that underpin cathelicidin-mediated modulation of airway epithelial cell responses to P. aeru-
ginosa infection. We show that P. aeruginosa-infected airway epithelial cells preferentially
internalise high levels of LL-37, resulting in lysosomal leakage and cathepsin B-mediated,
NLRP3-dependent, activation of caspase-1. These epithelial cells release IL-1β and IL-18 and
promote neutrophil influx. This represents a novel mechanism, contrasting significantly with
processes in myeloid cells, by which a host defence peptide can provide the second signal
required by infection-compromised epithelial cells to promote an inflammasome-mediated
protective inflammatory response.
Results
LL-37 induces secretion of neutrophil-chemotatic factors during airway
epithelial cell infection with P. aeruginosa
We previously demonstrated that therapeutic airway administration of the human cathelicidin
LL-37, in a murine model of pulmonary infection with P. aeruginosa strain PAO1, promoted
pathogen clearance [8]. This enhanced host defence occurred in the absence of any microbici-
dal effect of LL-37 in the infected lung, by enhancing neutrophil infiltration. Similarly, induc-
tion of endogenous murine cathelicidin was essential for an optimal neutrophil response in
this pulmonary infection model, and for effective clearance [8]. Importantly, this cathelicidin-
mediated protective pro-inflammatory response only occurred in the presence of the bacteria,
demonstrating an interaction between infection and HDP-mediated modulation of host
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defence. However, no cathelicidin-mediated differences in the pulmonary cytokine responses
to infection assessed in that study were found. Pulmonary infection with P. aeruginosa in this
murine model leads to extensive exposure of the airway epithelium to this pathogen. P. aerugi-
nosa can bind and invade (or be internalized by) airway epithelial cells, and induce inflamma-
tory responses [20–23]. Our previous demonstration that LL-37 can modulate the response of
airway epithelial cells to P. aeruginosa infection [19] therefore prompted us to investigate
whether these cells could be responsible for enhanced neutrophil recruitment.
An in vitro assay was established to analyse the neutrophil chemotactic properties of condi-
tioned media, containing soluble mediators released by primary human bronchial epithelial
(NHBE) cells that had been treated for 3 hours with LL-37 and P. aeruginosa strain PAO1 or
controls. This timepoint was selected to examine the early responses of epithelial cells interact-
ing with an invading pathogen, well in advance of any epithelial cell death, and because signifi-
cant LL-37-enhanced neutrophil influx into the Pseudomonas aeruginosa-infected mouse lung
had been observed to be well established by 6 hours after infection with LL-37 exposure in
vivo, implying an early change in signalling responses [8]. Peripheral blood neutrophils, iso-
lated from healthy human donors, were allowed to migrate through a ChemoTx migration
chamber towards conditioned media and subsequently quantitated. Significantly more neutro-
phils migrated towards conditioned media from PAO1-infected NHBE cells exposed to LL-37,
than to media from infected cells exposed to a scrambled control LL-37 peptide (Fig 1A and
1B). This was also significantly greater than the responses to media conditioned by NHBE cells
exposed to PAO1 or LL-37 alone (which were not significantly above background control
level) and greater than the sum of these conditions, demonstrating a synergistic effect compati-
ble with our in vivo observations [8]. These data demonstrate that LL-37 can modulate airway
epithelial cell responses to P. aeruginosa infection to induce mediators capable of promoting
neutrophil migration to the site of infection.
LL-37 induces secretion of IL-1β and IL-18 during airway epithelial cell
infection with P. aeruginosa
To evaluate the differences between conditioned media from PAO1-infected NHBE cells
treated with LL-37 and those only infected, or only treated with LL-37 (or exposed to scram-
bled LL-37), protein microarrays and confirmatory ELISAs were conducted. Whereas no sig-
nificant difference was seen between the different samples in the levels of IL-8 by ELISA (Fig
2A), or levels of CXCL1/KC, IL-1α, IL-1ra, MIF, or Serpin E1 in protein microarrays (S1
Table), both IL-1β and IL-18 were induced by 3 hours of treatment with LL-37, and secreted at
higher levels in LL-37-treated infected cells than in cells treated with LL-37 or PAO1 alone
(Fig 2B and 2C). Induction of IL-1β was significantly higher in response to combined stimuli,
and greater than the sum of either stimuli individually, with PAO1 alone unable to induce an
IL-1β response from these cells. Scrambled LL-37 had no effects, demonstrating the specificity
of the LL-37 peptide. These data demonstrate that LL-37 exposure can promote the release of
the pro-inflammatory cytokines IL-1β and IL-18 by airway epithelial cells during P. aeruginosa
infection, with the potential to induce cellular inflammatory host responses.
LL-37 promotes expression of IL-1β by human and murine myeloid cells in
a P2X7R-independent manner
Previous studies have demonstrated that cathelicidin can promote the release of IL-1β in mye-
loid cells, in which IL-1β transcription has been induced by pre-treatment with LPS [16, 17].
To confirm these previous observations in our systems, primary human blood-derived mono-
cytes were isolated, pretreated with LPS, and exposed for 3 hours to LL-37 or ATP (as a
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Fig 1. LL-37 induces the release of neutrophil-chemotatic factors from airway epithelial cells during infection with P. aeruginosa. A) Representative
examples of neutrophil migration assayed in ChemoTx chambers. Human neutrophils were assayed migrating towards chambers containing filtered
conditioned supernatant from NHBE cells treated for 3 hours with media only (untreated control), 20 μg/ml LL-37, 20 μg/ml ScrLL-37, PAO1 at 10:1 MOI,
PAO1 + LL-37 or PAO1 + ScrLL-37. Migrated cells were stained with 1 μM Calcein AM for 15 minutes at 37˚C, and imaged by microscopy. B) Quantitation of
migrating neutrophils shown in A, expressed as fold change compared to untreated control. Data represent means +/- SEM from n = 3–6 separate experiments
performed with neutrophils isolated from a different donor for each experiment, ��� p< 0.001, �� p<0.01, � p< 0.05 versus PAO1 + LL-37 condition, by 2-way
ANOVAs with Bonferroni Post-test, to examine the effect of PAO1 infection, with or without LL-37, or scrLL-37 treatment. ns = no significant difference.
https://doi.org/10.1371/journal.ppat.1007694.g001
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Fig 2. LL-37 induces secretion of IL-1β and IL-18 during airway epithelial cell infection with P. aeruginosa. ELISA quantitation of human cytokines IL-8 (A),
IL-1β (B) and IL-18 (C) released from NHBE cells treated for 3 hours with media only (control), 20 μg/ml LL-37, PAO1 at 10:1 MOI, PAO1 + LL-37, 20 μg/ml
ScrLL-37, or PAO1 + ScrLL-37. Data represent means +/- SEM from n = 3 independent experimental repeats, �� p<0.01, � p< 0.05 versus PAO1 + LL-37
condition, by 2-way ANOVAs with Bonferroni Post-test, to examine the effect of PAO1 infection, with or without LL-37, or ScrLL-37 treatment. ns = no
significant difference.
https://doi.org/10.1371/journal.ppat.1007694.g002
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positive control). As previously described, LL-37 significantly induced the release of IL-1β,
although it was a log less effective than ATP (Fig 3A and 3B). However, in contrast to the pre-
vious proposal that LL-37 might act directly as an agonist of P2X7 receptor (P2X7R) [16], inhi-
bition of P2X7R had no significant impact on LL-37-mediated induction of IL-1β (Fig 3C).
This was in contrast to significant inhibition of ATP-mediated IL-1β release. To confirm this
observation, LPS pre-treated peritoneal macrophages from wild type or P2X7R-deficient mice
were exposed to LL-37 (Fig 3D and 3E). Exposure to LL-37 induced IL-1β release from both
wild type cells and P2X7R-deficient cells, which (as expected) did not respond to ATP. These
data confirm the capacity of LL-37 to promote IL-1β by myeloid cells, but indicate a P2X7R-
independent mechanism.
Having confirmed the capacity of LL-37 to induce myeloid cell production of IL-1β, we
then evaluated the responses to P. aeruginosa PAO1 and LL-37 in myeloid cells, as a parallel to
the conditions applied in the airway epithelial cell experiments. Primary human blood mono-
cyte-derived macrophages (MDM), pre-treated with LPS, expressed IL-1β in response to posi-
tive control treatment with ATP, as expected (Fig 3F), although at lower levels than primary
monocytes (Fig 3A). Concomitant addition of LL-37 did not further enhance this response.
Further treatments were conducted in the absence of LPS pre-treatment, to model the
response to live bacteria. Under these conditions, 3 hours after PAO1 infection alone, but not
LL-37 alone, exposure had promoted a significant release of IL-1β (Fig 3F). This was not
enhanced by the concomitant addition of LL-37. Assessment of caspase-1 activation, as the
driver of IL-1β release, was then undertaken using a live cell fluorescent probe (FLICA). Cas-
pase-1 activation in MDM mirrored the release of IL-1β (Fig 3G), with ~35% of LPS pre-
treated cells showing activated caspase-1 after 3 hours exposure to ATP, and ~70% of cells acti-
vating caspase-1 in response to a 3 hour infection with live PAO1. Responses were not affected
by the presence of LL-37 in these cells.
P. aeruginosa infection is known to activate the inflammasome in macrophages via NLRC4
detection of flagellin and the type-3 secretion system inner-rod protein [24–26]. Involvement of
Pseudomonas with NLRP3 is less widely reported, but it has been shown to cause activation of
NLRP3 to trigger autophagy in macrophages [27], and was shown to activate NLRP3 via mito-
chondrial perturbation in airway epithelial cells expressing mutant CFTR [28]. More recently,
NLRP3 activation was also described in macrophages during longer term (16 hour) infection by
Pseudomonas via the action of guanylate binding proteins [29]. Thus, to evaluate whether MDM
and NHBE cell types both had the required components to facilitate equivalent responses,
Q-RTPCR was performed to examine transcription of the genes encoding NLRC4, NLRP3 and
caspase-1 and -4 (Fig 3H). Whereas NLRP3 and caspase-1 and -4 were expressed at equivalent
levels, no expression of NLRC4 was detected in NHBE cells, in contrast to MDM. NLRC4 was
also undetectable in the bronchial epithelial cell line 16HBE14o- (S1 Fig). This absence of
NLRC4 expression in bronchial epithelial cells may explain the minimal IL-1β responses of these
cells to P. aeruginosa alone (Fig 2B). Taken together these data suggest that macrophages may be
maximally stimulated by infection with P. aeruginosa, but that airway epithelial cells may need
an additional signal to respond. This suggested that the differential in vivo host responses to pul-
monary infection with P. aeruginosa in the presence and absence of cathelicidin is more likely
related to epithelial cell responses. Therefore, subsequent studies focused on epithelial cells.
LL-37 induces activation of caspase-1 during airway epithelial cell infection
with P. aeruginosa
The FLICA probe was next used to confirm that the pattern of caspase-1 activation in NHBE
cells recapitulated the IL-1β responses. Whereas treatment with LL-37 alone, for 3 hours,
Synergistic inflammasome activation by cathelicidin and Pseudomonas aeruginosa in epithelial cells
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Fig 3. LL-37 promotes expression of IL-1β by human and murine myeloid cells in a P2X7R-independent manner. A and B) Primary human blood-derived
monocytes were isolated, pretreated with 10 ng/ml E. coli 0111:B4 LPS for 3 hours, then exposed for 1 hour to 50 μg/ml LL-37, 5 mM ATP or untreated.
Supernatants were assessed for IL-1β by ELISA (A), comparing the effect of LL-37 or ATP on LPS-stimulated or unstimulated cells using 2-Way ANOVAs with
Bonferroni post-tests (��� p<0.001, �� p<0.01, � p<0.05, data represent mean +/- SEM for n = 8 per condition), or by western blot (B) detection of pro- and
mature IL-1β. (C) Primary human blood-derived monocytes pre-treated with 10 ng/ml LPS as in (A) and also treated with 1 μM KN62 prior to addition of
50 μg/ml LL-37 or 5 mM ATP. Supernatants were assessed for IL-1β by ELISA, and the impact of KN-62 was determined using unpaired t-test (��� p<0.001,
data represent mean +/- SEM for n = 4 per condition). D and E) Murine peritoneal macrophages from WT or P2X7R-/- mice were exposed to LL-37 (10 or
50 μg/ml) or ATP (5 mM) for 30 minutes with supernatants analysed by ELISA, and assessed by 1-way ANOVA with Bonferroni multiple comparisons post-
test, �� p<0.01, � p<0.05, data represent mean +/- SEM for n� 3 per condition. F and G) Human MDM were treated with either 20 μg/ml LL-37, PAO1 at 10:1
MOI or 10 ng/ml LPS for 3 hours, or 5 mM ATP only for 1 hour, or 10 ng/ml LPS for 3 hours followed by 5 mM ATP for 1 hour +/- 20 μg/ml LL-37. Data
represent mean +/- SEM for n = 3–6 per condition, ��� p< 0.001, �� p<0.01, � p<0.05, by 2-way ANOVA with Bonferroni Post-test, with supernatants
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caused activation of caspase-1 in a small (~7%) proportion of NHBE cells, P. aeruginosa PAO1
had a very limited effect (Fig 4A), in agreement with previous studies on lung epithelial
responses to Pseudomonas [30]. However, in the presence of LL-37, a 3 hour infection with
PAO1 led to an increase in caspase-1 activated NHBE cells (to ~16%; Fig 4A) and 16HBE14o-
cells (S2 Fig), significantly greater than to LL-37 or PAO1 alone, with the same synergistic pat-
tern observed as for IL-1β release. These responses were a striking contrast to the responses of
MDMs (Fig 3G), and suggested the possibility of differential ability to respond to these stimuli.
In further contrast to MDM (Fig 3G), LPS pre-treated primary airway epithelial cells did not
significantly activate caspase-1 in response to ATP (Fig 4A). However, interestingly, LL-37
also potentiated the responses to ATP in these cells, in manner similar to that observed for P.
aeruginosa. These data suggest that cathelicidin may potentiate inflammasome activation in
response to stimuli that are suboptimal activators in airway epithelial cells.
Having previously showed that, over a longer time frame, LL-37 preferentially induced cell
death in cells infected with P. aeruginosa PAO1, in the 16HBE14o- airway epithelial cell line
[19], we re-examined this model in light of our new data. Significant LL-37-mediated enhance-
ment of cell death in PAO1-infected cells, assessed by TUNEL staining at 6 hours after infec-
tion, also showed a synergistic pattern (Fig 4B). LL-37 treatment with PAO1 infection induced
significantly greater cell death (~30%) than in cells treated with LL-37 alone, or those infected
without cathelicidin. This could be blocked by the caspase-1 inhibitor, YVAD-CHO, reducing
cell death to the level observed in LL-37-only treated cells. Having determined that the syner-
gistic component of this epithelial cell death was capase-1 dependent, a live cell fluorescent
probe was used to quantify activation of the apoptosis-inducing caspases-3 and -7, preceding
cell death. Low level caspase 3/7 activation was induced in response to stimuli (Fig 4C). How-
ever, in contrast to the induction of cell death, the proportion of cells in which these caspases
were activated was equivalent in cells irrespective of whether they had received 3 hours expo-
sure to LL-37 or PAO1 alone, or LL-37 exposure concomitant with PAO1 infection (Fig 4C).
Using live cell fluorescent probes to evaluate both caspase-1 and caspase-3/7 in the same cells,
showed that activation of these caspases was mutually exclusive in cells, with classical con-
densed morphology seen in apoptotic caspase-3/7 positive cells, and intense caspase-1 foci
seen in FLICA positive cells, but no double positive cells seen (Fig 4D). These data demon-
strate that cathelicidin-mediated capase-1 activation underpins the LL-37-induced death of P.
aeruginosa-infected cells that we have previously observed [19].
LL-37 preferentially accumulates in infected epithelial cells, activating
caspase-1 via a P2X7R- and FPRL-1-independent mechanism
To determine the mechanism by which LL-37 could activate caspase-1 in airway epithelial
cells, previously identified potential receptors for LL-37 were examined. Neither inhibition of
FPRL1 (Fig 5A), nor inhibition of P2X7R (Fig 5B), by pre-incubation with WRW4 and KN-62
respectively, were able to inhibit LL-37-mediated activation of caspase-1 during PAO1 infec-
tion. The latter data are compatible with our evidence for a P2X7R-independent mechanism of
LL-37-mediated IL-1β release in MDM. These findings suggested that modulation of airway
epithelial cell caspase-1 activation is mediated by mechanisms other than the classically
described LL-37 receptors.
assessed for IL-1β by ELISA (F) and caspase-1 activity assessed by FLICA activity assay (G). ns = no significant difference. H) Real Time PCR detection of
inflammasome components using commercial TaqMan Gene Expression assays for NLRC4, NLRP3, caspase 1 (Casp1) and caspase 4 (Casp4) in MDM (white
columns) and NHBE (black columns) cells. ND = not detectable.
https://doi.org/10.1371/journal.ppat.1007694.g003
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Fig 4. LL-37 induces activation of caspase-1 during airway epithelial cell infection with P. aeruginosa. A) FLICA Caspase 1 activation assay quantitation in
NHBE cells, assessed by fluorescence microscopy, 3 hours post-treatment with either media only (control), 20 μg/ml LL-37, PAO1 at 10:1 MOI, PAO1 + LL-37,
10 ng/ml LPS for 3 hours, 5 mM ATP only for 1 hour, or 10 ng/ml LPS for 3 hours followed by 5 mM ATP for 1 hour +/- 20 μg/ml LL-37. Data represent
means +/- SEM from n = 3–6 independent experimental repeats, ��� p< 0.001, �� p< 0.01, by 2-way ANOVA with Bonferroni Post-test. B) Quantitation of
percentage of cell death at 6 hours post-treatment, assayed by TUNEL staining in 16HBE14o- cells treated with either media only (control), 20 μg/ml LL-37,
PAO1 at 10:1 MOI, or PAO1 + LL-37 +/- 25 μM YVAD-CHO Caspase 1 inhibitor. Data represent means +/- SEM from n = 5 independent experimental
repeats, ��� p< 0.001, �� p< 0.01, � p< 0.05, versus PAO1+LL-37 condition, by 2-Way ANOVA with Bonferroni Post-test, or by unpaired t-test for the
separate evaluation of caspase-1 inhibition. C) Quantitation of apoptosis as measured by Caspase 3/7 Magic Red probe in NHBE cells, 3 hours post-treatment
with either media only (control), 1 μM staurosporine, 20 μg/ml LL-37, PAO1 at 10:1 MOI, or PAO1 + LL-37. Data represent means +/- SEM from n = 3
independent experimental repeats, ��� p< 0.001, �� p<0.01, � p<0.05 by 2-way ANOVA with Bonferroni Post-test, or by unpaired t-test to evaluate the
positive control staurosporine. D) Confocal microscopy images, at high and low power magnification, of NHBE cells treated with 20 μg/ml LL-37 and PAO1 at
10:1 MOI, co-stained with Caspase 1 FLICA probe (green) and Caspase 3/7 Magic Red probe (red), showing mutual exclusivity of cell staining with these
probes. Representative of n = 4 separate experiments.
https://doi.org/10.1371/journal.ppat.1007694.g004
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To further characterise the nature of this interaction, the requirement for bacterial
secreted factors and/or live bacteria was examined. Substitution of heat-killed PAO1, or
bacterial supernatant, for live PAO1, did not replicate the LL-37-enhanced caspase-1 activa-
tion (Fig 5C). Although, levels of caspase-1 activation in these cells increased in the presence
of LL-37, this was no greater than the response to the LL-37 alone control. However, live
PAO1 genetically modified to delete the T3SS operon [31], which renders this Pseudomonas
strain incapable of invading the cell, retained this function. These data indicate that secreted
factors are not sufficient, and that components of the bacterial T3SS are not required, but
detection of live P. aeruginosa by the epithelial cells is sufficient for synergistic activation of
capase-1 by LL-37.
Pseudomonas can attach to epithelial cell surfaces and can invade (or be internalized by)
epithelial cells [21, 23, 32, 33]. Timelapse imaging demonstrated cell-associated aggregates of
bacteria rapidly accumulated in infected epithelial cell cultures (Fig 5D; S3 Fig). Subsequent
addition of TAMRA-labelled LL-37 to these cultures, 30 min after infection (time “0”), showed
the peptide steadily accumulating inside cells associated with large P. aeruginosa aggregates
(white arrows). Using confocal microscopy of live GFP-labelled PAO1, entry of bacteria into
the epithelial cells was observed (Fig 5E, white arrow heads) with others accumulating on the
surface. Extensive accumulation of TAMRA-LL-37 throughout the cytoplasm (white arrows;
Fig 5D) only occurred in cells associated with PAO1 aggregates, and those cells were found to
have ~4-fold greater level of associated PAO1 aggregates than cells in which LL-37 had not
accumulated (S4 Fig), demonstrating an association between magnitude of infection and high
level accumulation of intracellular LL-37. We separately confirmed that the PAO1-infected
epithelial cells were not dead prior to addition of LL-37, using the aqueous live cell marker
Sytox Green. Sytox Green remained excluded from cells at one hour after infection, at which
point TAMRA-LL-37 was added. Subsets of cells were then observed to initially accumulate
TAMRA-LL-37 at their membrane, followed by extensive LL-37 uptake into the cytoplasm
and Sytox Green positivity (S5 Fig). This may not indicate the onset of cell death, as LL-37 has
been shown to enable entry of various materials (including nucleic acid stains and labelled
DNA) across the membrane of live cells [16, 34]. However, these experiments demonstrate
that the data are not simply LL-37 accumulating non-specifically in dead cells, subsequent to
any early bacterially-induced cytotoxicity. To examine the consequence of this, GFP-PAO1-in-
fected, live NHBE cells, exposed to TAMRA-LL-37, were also stained for caspase-1 activation,
using a biotin-labelled caspase-1 inhibitor YVAD, followed by brilliant violet-labelled strepta-
vidin (Fig 5E). Confocal imaging showed that caspase-1 activation occurred in the cells with
the most bacterial infection and uptake of LL-37. Taken together, these data demonstrate that
LL-37 preferentially accumulates inside airway epithelial cells most compromised by infection
with live bacteria, and leads to activation of caspase-1 by a P2X7R and FPRL-1 independent
mechanism.
Fig 5. LL-37 preferentially accumulates in infected epithelial cells, activating caspase-1 via a P2X7R- and FPRL-1-independent mechanism. NHBE cells
were exposed for 3 hours to media only (control), 20 μg/ml LL-37 only, PAO1/ heat killed PAO1/ P. aeruginosa strain T3SS at 10:1 MOI +/- 20 μg/ml LL-37, or
PAO1 supernatant +/- 20 μg/ml LL-37. Some cells were pre-exposed for 1 hour to FPRL1 inhibitor WRW4 (10 μM) (A), or P2X7R inhibitor KN-62 (20 μM)
(B). Caspase 1 activity was measured by FLICA assay (A–C). Data represent means +/- SEM from n = 3 independent experimental repeats, ��� p< 0.001, ��
p<0.01, � p<0.05, by 2-way ANOVA with Bonferroni Post-test. ns = no significant difference. D) Timelapse series of images (brightfield/fluorescence merge)
taken by confocal microscopy showing GFP-PAO1 (green) adhering to NHBE cells (white arrows) with concentration of TAMRA-labelled LL-37 (red), on
heavily infected cells. Scale bar = 100 μm. E) Representative maximum projection merged image of a field of NHBE cells stained with GFP-PAO1 (green),
TAMRA-labelled LL-37 (red), and Brilliant Violet-YVAD (blue). Scale bar = 50 μm. Inset shows cropped single plane of one NHBE cell demonstrating
GFP-PAO1 bacteria (white arrow heads) inside a TAMRA-LL-37 positive cell that is also positive for caspase 1 activation, indicated by Brilliant Violet-YVAD
staining. Scale bar = 10 μm.
https://doi.org/10.1371/journal.ppat.1007694.g005
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LL-37-mediated activation of caspase-1 during airway epithelial cell
infection with P. aeruginosa is NLRP3-dependent
To investigate the mechanism by which intracellular LL-37 activated caspase-1 in airway epi-
thelial cells, we examined the importance of NLRP3, previously implicated in LL-37-mediated
inflammasome activation in neutrophils [17]. The addition of the NLRP3-inhibiting, potas-
sium ion channel blocker Tetraethylammonium chloride (TEA), to PAO1-infected, LL-
37-treated NHBE cultures was found to significantly inhibit peptide-mediated activation of
caspase-1 in infected cells (Fig 6A). This was reduced to levels similar to that observed with
exposure to LL-37 alone, suggesting a role for NLRP3 in the synergistic induction phenotype.
To test the involvement of NLRP3 directly, NLRP3 expression was genetically modified in the
16HBE14o- cell line using both siRNA knock-down (Fig 6B) and CRISPR-mediated knock-
out (Fig 6C and 6D) airway epithelial models. NLRP3 siRNA transfection in 16HBE14o- cells
resulted in significantly lower levels of caspase-1 activation in PAO1-infected LL-37-treated
cells (Fig 6B). To definitively confirm these data, knock-out 16HBE14o- cell lines were gener-
ated by CRISPR/Cas9. Two separate mutant lines, B9 and G6 (both confirmed as single base
pair insertions causing a non-sense frameshift) were unable to significantly upregulate cas-
pase-1 activation above background stimulation levels upon LL-37 exposure of PAO1-infected
cells (Fig 6C). These NLRP3 knock-out cells were shown by western blot to have complete
absence of NLRP3 protein (Fig 6D). These data demonstrate that NLRP3 is required for
inflammasome-mediated synergistic activation of caspase-1 by uptake of LL-37 into P. aerugi-
nosa infected airway epithelial cells.
LL-37-induced activation of caspase-1 in P. aeruginosa infected epithelial
cells, and induction of neutrophil migration, is mediated by lysosomal
leakage of cathepsin B
LL-37 is known to interact with cell membranes; permeabilising bacterial outer membranes
[35, 36] and the membranes of apoptotic mammalian cells [37, 38]. LL-37 has also been shown
to traffic into human airway epithelial cells [39], and specifically to lysosomes and endosomes
in THP-1 cells [40]. The release of enzymes cathepsin B and cathepsin D from compromised
lysosomal compartments have been shown to induce inflammasome activation [41, 42]. Thus,
the extent to which LL-37 could induce lysosomal disruption in infected airway epithelial cells
was examined.
Loading of NHBE cells with fluorescently labelled 10 kDa Dextran resulted in punctate
accumulation of fluorescent signal in lysosomes (Fig 7A). Subsequent infection of these cells
with PAO1, and exposure to TAMRA-labelled LL-37, resulted in dextran leakage from the
lysosomes of a subset of epithelial cells, evidenced by marked diffusion of the fluorescent signal
throughout the cell cytoplasm (Fig 7A, white arrows). Visualisation of the TAMRA-labelled
LL-37 localisation, demonstrated that the cells with lysosomal leakage were those cells prefer-
entially internalising LL-37 during infection (Fig 7A; red cells). Where cells did not internalise
LL-37, the punctate lysosomal location of the dextran remained intact. Quantification of the
percentage of epithelial cells with lysosomal leakage (Fig 7B), demonstrated that this was sig-
nificantly greater in infected cells exposed to LL-37, when compared to LL-37 alone or PAO1
infection alone, recapitulating the pattern for caspase-1 activation.
To evaluate the significance of leakage of lysosomal cathepsin B and D, inhibitors CA-
074-Me [43]) and Pepstatin A [44] were used. Whereas inhibition of cathepsin B significantly
inhibited the synergistic induction of caspase-1 activation in PAO1-infected primary NHBE
cells (Fig 7C) and 16HBE14o- cell (S6 Fig) exposed to LL-37, inhibition of cathepsin D did not.
Taken together, these data demonstrate that intracellular LL-37 in PAO1-infected airway
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Fig 6. LL-37-mediated activation of caspase-1 during airway epithelial cell infection with P. aeruginosa is NLRP3-dependent. Airway epithelial cells, either
WT NHBE cells (A), NLRP3 siRNA treated 16HBE14o- cells (B), or NLRP3 CRISPR stable 16HBE14o- cell lines (C), were exposed for 3 hours to media only
(control), 20 μg/ml LL-37, PAO1 at 10:1 MOI, PAO1 + LL-37. Caspase 1 activity was quantitated by FLICA assay in A) NHBE cells +/- inhibition of NLRP3 by
5 mM TEA, B), 16HBE14o- cells treated with either non-targeting control siRNA (white bars) or NLRP3 siRNA (black bars), C) WT 16HBE14o- cells (white
bars) versus NLRP3 CRISPR mutant cells (black bars), following establishment of two CRISPR-targeted NLRP3 mutant cell lines with no detectable NLRP3
expression (demonstrated by western blot of NLRP3 (117 kDa)) in WT cells versus NLRP3 mutant cell lines (D); Actin blot shown as a loading control). In A, B
and C, ��� p< 0.001, �� p<0.01, � p<0.05, by 2-way ANOVA with Bonferroni Post-test. Data represent mean +/- SEM for n = 3 independent experimental
repeats.
https://doi.org/10.1371/journal.ppat.1007694.g006
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epithelial cells, leads to NLRP3 inflammasome-mediated capase-1 activation via induction of
lysosomal leakage and the release of cathepsin B.
To determine the physiological relevance of lysosomal dependent activation of caspase-1 in
these cells, the cathepsin B inhibitor was applied to the initial neutrophil migration assay
detailed in Fig 1. NHBE cells were pre-incubated with CA-074-Me cathepsin B inhibitor,
before infection with PAO1 and concomitant exposure to LL-37, after which conditioned
media was generated and filtered. Inhibition of cathepsin B significantly reduced the level of
IL-1β release by LL-37-treated infected cells, to the level of those treated with LL-37 alone (Fig
7D). Application of these conditioned media to the primary human neutrophil migration
assay, demonstrated that cathepsin B inhibition blocked LL-37-promoted production of
neutrophil chemotactic factors by PAO1-infected airway epithelial cells. (Fig 7E). These data
demonstrate that the enhanced neutrophil chemotactic capacity of airway epithelial cell condi-
tioned media, results from LL-37-mediated activation of the NLRP3 inflammasome and cas-
pase-1 in P. aeruginosa-infected cells, operating via a mechanism of lysosomal leakage of
cathepsin B (Fig 8).
Discussion
Pseudomonas aeruginosa is an important, opportunistic, multidrug-resistant human pathogen.
It is associated with a wide range of serious acute and chronic infections, including ventilator-
associated pneumonia and sepsis syndromes, and is the predominant pulmonary infection
leading to fatal deterioration of lung function in patients with CF [45]. New interventional
approaches for the treatment of P. aeruginosa are urgently needed in the context of the increas-
ing global threat of antimicrobial resistance, and may be informed by a greater knowledge of
effective innate host defence. Cathelicidins are a vital, non-redundant antimicrobial host
defence peptide component of innate host defence, necessary for in vivo protection against
infections of the lung, skin, intestinal tract, urinary tract and eye (reviewed in [7]). We have
previously demonstrated that innate antimicrobial host defence peptides of the cathelicidin
family can enhance the clearance of pulmonary P. aeruginosa in vivo by amplifying the protec-
tive neutrophilic inflammatory response [8]. However, the mechanism by which cathelicidin
promotes protective pulmonary inflammation in the context of an infectious threat, but not
when delivered to the quiescent lung, remained unclear.
Here we describe a novel mechanism to promote innate host defence against P. aeruginosa
infection, mediated by a modulatory function of the cathelicidin LL-37 upon infected airway
epithelial cells. Unless rapidly cleared by professional phagocytes, P. aeruginosa entering the
lung will predominantly encounter airway epithelial cells, to which this pathogen can adhere
and invade, or be internalised; a process that could be a pathogenic mechanism to avoid host-
mediated killing, or a host defence mechanism [21, 23, 32, 33, 46–48]. Under permissive con-
ditions, this can create a safe niche for survival and intracellular proliferation of the bacteria
in compromised epithelial cells [47]. However, the release of danger signals, coupled with
Fig 7. LL-37-induced activation of caspase-1 in P. aeruginosa infected epithelial cells, and induction of neutrophil
migration, is mediated by lysosomal leakage of cathepsin B. A) Confocal microscopy images of NHBE cells loaded with
Alexa 488 Dextran (green) +/- treatment with TAMRA-labelled LL-37 (red), with white arrows indicating lysosomal
leakage, quantified in (B). �� p<0.01, � p<0.05, data represent mean +/- SEM for n� 3 per condition. C—E) NHBE cells
were treated for 3 hours with media only (control), 20 μg/ml LL-37, PAO1 at 10:1 MOI, or PAO1 + LL-37. Some cells were
pre-exposed for 1 hour to cathepsin B inhibitor CA-074-Me (20 μM) (C—E), or cathepsin D inhibitor Pepstatin A (20 μM)
(C). C) Caspase 1 activation was assessed by FLICA assay D) IL-1β in the supernatant was quantified by ELISA. E)
Neutrophil migration in ChemoTx plates towards conditioned supernatant from NHBE cells was assessed. Data represent
means +/- SEM from n = 3–6 independent experimental repeats, ��� p< 0.001, �� p<0.01, � p< 0.05, by 2-way ANOVA
and Bonferroni post-test. ns = no significant difference.
https://doi.org/10.1371/journal.ppat.1007694.g007
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altruistic cell death to remove a small number of infected cells which have internalised multiple
organisms, could protect the host [19, 48, 49]. In contrast to professional phagocytes, a rela-
tively quiescent epithelium is desirable, unless the initial host defence has been overwhelmed
and the epithelial barrier is compromised by infection. In this context, a requirement for mul-
tiple signals to licence significant epithelial cell induction of a robust neutrophilic response in
the lung may be a necessary protective safeguard.
Fig 8. Schematic representation of the mechanism of LL-37-mediated inflammasome activation in Pseudomonas
infected airway epithelial cells. Bacterial attachment and internalization into epithelial cells concentrates LL-37
peptide (released by activated cells) into these compromised, infected epithelial cells. Entry of bacteria and cathelicidin
into the cell triggers activation of the NLRP3 inflammasome via induction of lysosomal leakage and the release of
cathepsin B. Caspase 1 activation in these cells facilitates release of pro-inflammatory cytokines IL-1β and IL-18,
promotes recruitment of neutrophils to the affected area, enhances protective inflammation, and may lead to altruistic
cell death of the infected cell.
https://doi.org/10.1371/journal.ppat.1007694.g008
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We demonstrate that P. aeruginosa infection of airway epithelial cells in vitro does not acti-
vate the inflammasome without an additional signal, perhaps due to an absence of NLRC4
expression. However, infection in the presence of cathelicidin promotes caspase-1 activation,
release of IL-1β and IL-18, and the influx of neutrophils. Whether the key source of this cathe-
licidin is activated local macrophages or epithelial cells (with potential responses to cathelici-
din produced by the infected epithelial cell itself, or by its neighbours), or degranulating
neutrophils entering the site in an escalating inflammatory response in the lung, remains to be
determined. An additional limitation of this study was the use of submerged airway epithelial
cell cultures. While both undifferentiated primary cells and an immortalised cell line showed
the same responses to stimuli, we cannot exclude the possibility that cells differentiated at air-
liquid interface could respond differently. Regardless, the synergistic activity of infection and
peptide exposure in these cells was found to be mechanistically dependent upon interaction of
the epithelial cells with live P. aeruginosa, but not dependent upon T3SS, and to be dependent
upon cathelicidin-mediated release of cathepsin B from lysosomes or phagolysosome in
infected cells, inducing activation of the NLPR3 inflammasome. The process by which infec-
tion increased the uptake of LL-37 into those compromised epithelial cells, remains the focus
of ongoing work. In this regard, the significance of Pseudomonas-induced ceramide-enriched
lipid platforms, will be of interest; having critical roles in pathogen internalisation, NF-κB acti-
vation and IL-1β transcription in response to the infection [46, 50]. Once inside the cell, LL-37
has been shown to traffic to lysosomes and endosomes in THP-1 and epithelial cells [39, 40], is
known to localise in and cross cellular membranes, and can induce pore formation in apopto-
tic cell membranes [37, 38]. Release of cathepsin B and cathepsin D from compromised lyso-
somal compartments has been shown to induce the activation of inflammasomes [41]. In
addition, the cathepsin B inhibitor CA-074-Me has been shown to inhibit activation of the
NLRP3 inflammasome [43]. In our studies, the effects of LL-37 were blocked by a cathepsin B
inhibitor, with no impact of cathepsin D inhibition. Although inflammasome activation was
required for the synergistic danger response observed in infected, peptide-treated cells, parallel
effects of cathelicidin may also contribute to this process. In that regard, it is interesting to
note that LL-37 also potentiated airway epithelial cell activation of caspase-1 in response to
ATP, to which, in contrast to myeloid cells, airway epithelial cells were largely unresponsive.
Given this apparent capacity to potentiate suboptimal inflammasome-activating signals in air-
way epithelial cells, the impact upon infection with other, clinical isolates of P. aeruginosa, and
potentially also infections with other bacteria and/or viruses, will be of great future interest.
Regardless, this synergistic activation of inflammasome-mediated neutrophilic inflammation
is compatible with our in vivo observations; in which endogenous cathelicidin was required
for maximal neutrophil-mediated inflammation, and therapeutic delivery of LL-37 enhanced
neutrophil responses to P. aeruginosa infection [8]. It is also worth noting that while LL-37
alone was capable of inducing low level NLRP3-independent caspase-1 activation in our epi-
thelial cell studies (Fig 6), this was not sufficient to promote significant neutrophil chemotaxis
(Fig 1). Similarly, delivery of LL-37 alone (in the absence of infection) to the murine lung did
not induce pulmonary neutrophil influx in vivo [8]. Our new in vitro data now justify future
mechanistic in vivo research to examine the impact of cathelicidin on release of IL-1β and IL-
18 responses in murine models of pulmonary P. aeruginosa infection, to determine the factors
modified by induction of these cytokines to act as the direct chemokines for neutrophils in our
in vitro and in vivo models, and the effect of NLRP3 deficiency on the efficacy of therapeutic
administration of cathelicidin.
Inflammasomes have been widely investigated in immune effector cells, particularly macro-
phages, but are less well studied in epithelial cells. Nevertheless, recent research has shown the
biological importance of epithelial cell inflammasome-mediated responses against pathogens
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(summarised in [51]). Of particular significance, studies in the gut have shown that inflamma-
some activation and pyroptosis are important in host defence against Salmonella infection,
helping to clear pathogens by removing an intra-cellular replication niche [52]. Although LL-
37-mediated cell death in our P. aeruginosa infected airway epithelial cells was caspase-1
dependent, the role of non-canonical pathways and gasdermin-D in this system remain to be
determined. It is therefore unclear whether this cell death should be described as a form of epi-
thelial cell pyroptosis. Furthermore, the relative significance of this, versus upregulated neutro-
phil responses, to the cathelicidin-enhanced protection against pulmonary P. aeruginosa in
vivo remains to dissected in future studies of lung infection models.
Evidence suggests that inflammasome activation can have significant consequences of pul-
monary diseases [53, 54], but the relative impacts of acute, potentially essential, protective acti-
vation, versus inappropriate, potentially damaging, chronic activation remains to be fully
elucidated. Despite this, it is clear that early innate immune responses of airway epithelial cells
constitute an important component of first line of defense against respiratory disease, and,
compatible with our data, lung epithelial cells can secrete IL-1β and IL-18 to induce the inflam-
matory response [51]. Although not of the same magnitude as myeloid cells in our studies, the
combined effect of epithelial cell cytokine production at sites of infection may be pivotal. Fur-
thermore, in addition to its capacity to directly stimulate the production of chemokines by
peripheral blood monocytes and lung epithelial cells [55, 56], LL-37 can also synergistically
enhance IL-1β-mediated production of cytokines and chemokines [57]. Similarly to the prop-
erties described in our manuscript, this potentiation was observed using concentrations of
cathelicidin observed in the inflamed the human lung in vivo [58], suggesting a mechanism for
further enhancement of the impact of the cathelicidin-mediated induction of IL-1β described
herein, in the context of pulmonary inflammation.
In conclusion, we therefore propose that cathelicidin-mediated NLRP3 inflammasome acti-
vation in infected airway epithelial cells represents activation of a “fire-alarm”; triggered by
escalating pulmonary inflammation to an overwhelming threat that necessitates epithelial-gen-
erated enhanced neutrophilic inflammation and potentially the altruistic death and removal of
compromised infected epithelial cells. This represents a novel modulatory function of an
important innate antimicrobial host defence peptide, with the potential to open opportunities
for the development of HDP-based therapeutics (or inducers) that can combine microbicidal
activity with immunomodulatory / “innate immune adjuvant” function. Such approaches aim
to harness the most effective, evolutionary-tested successes of the innate immune system as
alternative or complementary approaches to our conventional therapies, avoiding issues of
rapid generation of resistance by promoting pathogen clearance indirectly by modulatory
properties of the HDP. This “immunomodulatory antimicrobials” approach has the potential
to revolutionise our strategies to infectious diseases in a manner that could parallel the recent
successes seen in cancer immunotherapy, and is of high significance in the context of the
threat of antibiotic-resistance.
Methods
Ethics statement
For leukocytes isolated from healthy volunteer blood, informed written consent was obtained
from all subjects, AMREC reference no. 15-HV-013. All animal experiments were carried out
in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986 and
approved by the Home Office and the local Animal Ethical Review Group, University of Man-
chester, project license number 403076.
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Peptides, antibodies and inhibitors
LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES; MW 4493.33) and scrambled
LL-37 control peptide (ScrLL-37) (RSLEGTDRFPFVRLKNSRKLEFKDIKGIKREQFVKIL)
were custom synthesised by Almac (East Lothian, Scotland) using Fmoc solid phase synthesis
and reversed phase HPLC purification. Peptide identity was confirmed by electrospray mass
spectrometry, purity (>95% area) by RP-HPLC and net peptide content determined by amino
acid analysis. Lyophilised peptides were reconstituted in endotoxin free water at 5 mg/ml
stock concentration, determined to be endotoxin-free using a Limulus Amebocyte Lysate
Chromogenic Endotoxin Quantitation Kit (Thermo Scientific, UK), and stored at -20 ˚C. Pep-
tide functionality was confirmed by assessing anti-endotoxic activity.
IL-1beta antibody was from R&D systems and used at 100 ng/ml, anti-NLRP3/NALP3 anti-
body was used at 1:500 dilution, from Caltag Medsystems (Buckingham, U.K.; Cat. No. AG-
20B-0014-C100); anti-Beta-Actin antibody was used at 1:2000, from Sigma Aldrich (Merck
group, Darmstadt, Germany; Cat. No. A1978).
Caspase 1 inhibitor YVAD-CHO and the Formyl Peptide Receptor-Like 1 antagonist
WRW4 were from Calbiochem (Merck group, Darmstadt, Germany). Cathepsin B inhibitor
CA-074-Me was from Enzo Life Sciences (Exeter, U.K.). Cathepsin D inhibitor Pepstatin A,
Tetraethylammonium chloride (TEA), the purinergic receptor P2X7R inhibitor KN62, and
Staurosporine were from Sigma Aldrich.
Cell and bacterial culture
Normal Human Bronchial Epithelial (NHBE) primary cells (Lonza, Basel, Switzerland) from
two donors were purchased, cultured and maintained in BEBM media with supplements
(Lonza) and used throughout. No significant donor-dependent variation was observed.
16HBE14o- cell line (transformed human bronchial epithelial; a kind gift from Dieter Gruenert
at the University of California San Francisco) was maintained in DMEM containing 10% FBS,
2 mM L-glutamine and 1% Penicillin/Streptomycin (Pen/Strep). Cells were incubated in a
37˚C incubator with humidified atmosphere of 5% CO2, and grown on flasks or chamber
slides previously coated with a solution of Collagen (Cultrex, Trevigen, Gaithersburg, U.S.A.;
0.05 mg/ml) and Fibronectin (Sigma-Aldrich; 0.1 mg/ml) syringe-filtered through a 0.22 μm
filter.
Transfection of epithelial cells was performed using Lipofectamine 2000 (Invitrogen, Carls-
bad, U.S.A.) by following the manufacturers’ instructions. For transient transfection, cells
were transfected 48–72 hours prior to use. Transfection of control siRNA and NLRP3 siRNA
cells were performed using Lipofectamine 2000 reagent by following the manufacturers’
instructions. Cells were transfected 48–72 hours prior to use.
P. aeruginosa strain PAO1 was a gift from J. R. W. Govan (University of Edinburgh).
GFP-PAO1 was a gift from T. Tolker Nielsen (University of Copenhagen), and PAO1-dT3SS
was a gift from E. Gulbins (University Duisburg-Essen, Germany).
Isolation of human leukocytes
Peripheral blood neutrophils and monocytes were isolated from healthy human volunteers via
dextran sedimentation and Percoll discontinuous gradients as described [59]. Neutrophils
were used immediately in ChemoTx (Neuro Probe Inc., Gaithersburg, U.S.A.) migration assay
plates, at a concentration of 5 x 104 in PBS on the upper side of the membrane as per manufac-
turer’s instructions, and allowed to migrate towards conditioned BEBM media from NHBE
cells. Conditioned media was made by treating NHBE cells for 3 hours with LL-37, scrambled
LL-37 or Pseudomonas aeruginosa PAO1, either alone or in combination (all as detailed in Fig
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1), removing cell supernatant and filtering through a 0.22 μm-filter. Cells were allowed to
migrate for 1 hour at 37˚C, and migrated cells in the lower well were then stained with 1 μM
Calcein AM for 15 minutes before visualization/quantitation on an ‘EVOS fl’ fluorescence
inverted microscope (Fisher Scientific, Loughborough, U.K.).
Peripheral blood mononuclear cells were incubated at 4 x 106/mL in IMDM (PAA Labora-
tories, Somerset, UK) at 37˚C, 5% CO2, for 1 hour. Non-adherent cells were removed and
adherent monocytes were either used immediately, or cultured for 6 days in IMDM with 10%
autologous serum to generate monocyte-derived macrophages before treatment. Cells were
either primed with LPS (E. coli 0111:B4 Ultrapure, Invivogen (Toulouse, France); 10 ng/ml)
for 3 hours prior to addition of 5mM ATP (Sigma Aldrich) as required, or treated with LL-37
or ScrLL-37 (20–50 μg/ml) or PAO1 at a Multiplicity of Infection (MOI) of 10:1 as described
in the text. Cells were then used for preparation of RNA by RNeasy kit (Qiagen, Manchester,
U.K.), and cell supernatant used for cytokine analysis by ELISA as described below.
Murine peritoneal macrophages
Macrophages were prepared from adult male C57BL/6 (WT) mice (Harlan) and P2X7R KO
mice [60] as described previously [61]. In brief, the peritoneal cavity was lavaged with RPMI
1640 media (Sigma). Cells were collected by centrifugation (250 x g, 5 minutes) and plated in
24-well plates at a density of 5 x 105 cells/well in RPMI 1640 media (Sigma) supplemented with
5% FBS (PAA Laboratories), 100 units/ml penicillin, and 100 μg/ml streptomycin (Sigma).
Cells were cultured overnight (37 ˚C, 5% CO2) before non-attached cells were removed by a
media change. Cells were incubated with LPS (1 μg/ml for 2 hours) before treatment with LL-
37 and ATP as indicated.
Measurement of Caspase 1, Caspase 3/7 activity and TUNEL staining
16HBE14o- or NHBE cells were grown overnight at a seeding concentration of 0.8 x 105 per
well of a collagen/fibronectin-coated chamber slide. Prior to treatments below, cells were
washed twice in PBS (Gibco) and media was replaced with 250 μl serum-free BEBM (Lonza;
for NHBE cells) or DMEM (Gibco, Thermo Fisher UK; for 16HBEo- cells) and returned to
37˚C. PAO1 bacteria were grown in Luria Bertani (LB) Broth overnight at 37˚C with shaking
to achieve a stationary-phase suspension. Before use, bacterial suspensions were diluted 1:5 in
fresh LB broth and were returned to incubate at 37˚C for a further 2 hours to reach log phase.
Bacterial cultures were centrifuged at 1885 x g for 10 minutes, and bacterial supernatant was
removed and filter-sterilised through a 0.22 μM filter for use as required in the text. PAO1
were re-suspended in PBS, and diluted to an optical density (OD) 600 of 0.1, equating to 108
bacteria/ml. If required, bacteria were then heat killed by incubation at 70˚C for 30 minutes.
PAO1 were then added to cells in serum-free media at 10:1 MOI. LL-37 or control scrambled
peptide was added at the concentrations indicated in the text. If required, cells were pre-incu-
bated for 1 hour at 37˚C with inhibitors as indicated in the text, prior to addition of PAO1/
peptide. Cells and PAO1 were then returned to 37˚C for 3 hours.
Caspase 1 and Caspase 3/7 activity in live cells was assessed using FLICA and Magic Red
fluorescent probes respectively (ImmunoChemistry Technologies, Bio-Rad AbD Serotec,
Kidlington, U.K.), as per manufacturer’s instructions, in an incubator at 37˚C for 1 hour, with
the addition of 1 μg/ml Hoechst (Life Technologies) for the final 30 minutes. Cells were then
viewed using an EVOS fl inverted fluorescence microscope (Thermo Fisher U.K.) and analysed
using ImageJ software. Hoechst staining was used to calculate total cell number per field, and
Caspase 1 or 3/7 positivity of cells was manually assessed and counted for each field. TUNEL
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staining was performed with In Situ Cell Death Detection Kit (Roche Applied Science, West
Sussex, UK), according to manufacturer’s instructions, 6 hours after treatments.
Lysosomal leakage
NHBE cells seeded onto chamber slides were loaded for 3 hours with 20 μM Alexa 488 Dex-
tran, 10kDa (Life Technologies) at 37˚C in a humidified incubator, prior to treatment with
media only, 20 μg/ml LL-37 (or TAMRA-labeled LL-37), PAO1 at 10:1 MOI, or PAO1 + LL-
37 for a further 3 hours. Cells were then imaged live using a Leica SP5 confocal microscope.
Acquired images were subsequently analysed for evidence of lysomal leakage, indicated by a
diffusion of the green fluorescent signal throughout the cell cytoplasm, compared to bright
punctate fluorescence in media-only control conditions. Quantitation of leakage was per-
formed by expressing the number of cells displaying diffused green fluorescence as a percent-
age of the total number of cells in that field, across a minimum of 5 fields per experiment.
Western blotting
Cells were lysed with MPER lysis buffer (Life Technologies), centrifuged at 17,740 x g at 4 ˚C
for 10 minutes, and protein concentration determined by BCA assay. Equalized samples were
loaded onto 4–12% pre-cast polyacrylamide gel (Novex NuPage, Life Technologies), trans-
ferred to a Nitrocellulose membrane (Life Technologies), blocked for an hour with 5%
skimmed milk dissolved in TBS + 0.05% Tween-20 (TBS-Tw), and then incubated with pri-
mary antibodies as indicated in the text in blocking solution overnight at 4˚C. After washing
in TBS-Tw, membranes were incubated with appropriate secondary HRP-labelled antibodies
(DAKO, Agilent, Santa Clara, U.S.A.) in blocking solution, treated with ECL Prime substrate
(Sigma-Aldrich) in accordance with manufacturer’s instructions, and imaged on CL-Xposure
film (Thermo-Scientific).
ELISA
Cells (MDM, NHBE or 16HBEo-) were plated at 1.5 x 106 cells in 1 ml complete media in a
6-well plate and were then incubated overnight at 37˚C. Cells were infected for 3 hours with
PAO1 and LL-37, as per Caspase 1 activity section above. PAO1 was used at 10:1 MOI, LL-37
peptide was used at 20 μg/ml. Supernatants were collected and stored at -20 ˚C until use. The
concentration of IL-1β, IL-18 and IL-8 in cell supernatants was measured by ELISA kit
(eBioscience, Thermo Fisher U.K.), according to the manufacturer’s instructions.
qRT-PCR
RNA was made from treated cells using RNeasy mini kit (Qiagen), according to manufactur-
er’s instructions, and DNase treated with RQ1 DNase (Promega, Wisonsin, U.S.A.) for 30 min
at 37˚C. cDNA was prepared using TaqMan reverse transcriptase kit (Life Technologies).
Quantitative Real Time PCR was performed on a StepOne Real Time PCR machine (Life
Technologies), using Gene Expression Mastermix and TaqMan gene expression assays for
Caspase 1 (Assay ID Hs00354836_m1), Caspase 4 (Assay ID Hs01031951_m1), NLRP3 (Assay
ID Hs00918082_m1), NLRC4 (Assay ID Hs00892666_m1) and 18S (Assay ID 4319413E-
1403063) (all Life Technologies), as indicated in the text.
Construction of knock-out 16HBE14o- by CRISPR/Cas9
Two target sites for NLRP3 gRNA were designed according to the Zhang laboratory online
CRISPR designing tool [62]. Target sequences were cloned into vector pSpCas9(BB)-2A-GFP
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(PX458), a gift from Feng Zhang (Addgene plasmid # 48138; http://n2t.net/addgene:48138;
RRID:Addgene_48138), and transfected into 16HBE14o- cells with Lipofectamine 2000 (Invi-
trogen). Cells were flow sorted using a BD Biosciences FACS Diva 8.0.1 into single cells per
well of a 96-well plate, gating for live single cells and GFP-positivity. Isolated GFP-positive
cells were expanded, and tested for mutation by PCR and sequencing across the target area.
Two clones, B9 and G6, were identified as having single base pair insertions at the target site
causing a non-sense mutation that abolished NLRP3 protein production, as demonstrated by
Western blotting.
Confocal microscopy
For microscopy, other than in Caspase 1 FLICA and neutrophil migration experiments
described above, images were acquired on a Leica SP5 confocal microscope, with 63x oil objec-
tive. Cells were grown on Nunc LabTekII chamber coverslides (Sigma Aldrich), pre-coated
with Collagen and Fibronectin, overnight at 37˚C. Cells were imaged live after incubation with
GFP-PAO1, TAMRA-LL-37 (Almac), Biotin-YVAD-CMK (Cambridge Bioscience, Cam-
bridge, U.K.) and Brilliant Violet 421 Streptavidin (BioLegend, San Diego, U.S.A.), FLICA
Caspase 1 probe or MagicRed Caspase 3/7 probe (both ImmunoChemistry Technologies) or
Alexa 488 10kDa Dextran (Cat. No. D-22910, Life Technologies), as indicated in the text.
Images were acquired using Leica Application Suite software, and subsequently processed
(cropping/brightness-contrast only) in Adobe Photoshop CS5.1 software.
Statistics
Statistical analysis was performed using the GraphPad PRISM statistical package (GraphPad
software, La Jolla, USA) by 2-way ANOVA with Bonferroni Multiple Comparison Post-test
(Figs 1B, 2A–2C, 3A, 3F, 3G, 4A–4C, 5A–5C, 6A–6C and 7B–7E, and Supporting S3 and S6
Figs), 1-way ANOVA with Bonferroni Post-test (Fig 3D and 3E), or unpaired t-test (Figs 3C
and 4B between last 2 columns, 4C between first 2 columns), as stated in the respective figure
legends. p-values below 0.05 were considered significant. Figures show mean +/- SEM.
Supporting information
S1 Table. R+D Cytokine Profiler blot quantitation. Quantitation of additional cytokines
released from NHBE cells after treatment. A Cytokine Profiler dot blot (R+D Systems) was
probed with filtered supernatant from NHBE cells treated for 3 hours with either 20 μg/ml LL-
37 or 20 μg/ml LL-37 + PAO1 at 10:1 MOI. Quantitation was performed by measuring Inte-
grated Pixel Density of each cytokine spot in ImageJ. S1 Table lists the mean Integrated Pixel
Density values for 4 measurements from each cytokine in each condition.
(TIF)
S1 Fig. Real Time PCR (16HBEo- cells). Quantitative Real Time PCR of inflammasome com-
ponents NLRC4 and NLRCP3 in 16HBE14o- cells, showing no detectable NLRC4. Data repre-
sent means +/- SEM from n = 3 independent experimental repeats. ND = not detectable.
(TIF)
S2 Fig. FLICA (16HBEo- cells). FLICA Caspase 1 activation assay in 16HBE14o- cells treated
for 3 hours with media only (control), 20 μg/ml LL-37, 20 μg/ml ScrLL-37, PAO1 at 10:1 MOI,
PAO1 + LL-37 or PAO1 + ScrLL-37, demonstrating synergistic activation of caspase 1 activity
by PAO1 + LL-37 compared to either LL-37 alone or PAO1 alone. Data represent means +/-
SEM from n = 3 independent experimental repeats, ��� p< 0.001, �� p<0.01, � p<0.05, by
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2-way ANOVA with Bonferonni Post-test. ns = no significant difference.
(TIF)
S3 Fig. TAMRA-LL-37 and GFP-PAO1 on NHBE cells. Enlarged image of rightmost panel
from timelapse series shown in Fig 5D, showing NHBE cells treated with GFP-PAO1 (green)
at 10:1 MOI and 20 μg/ml TAMRA-LL-37 (red). Cell outlines from the brightfield channel
have been highlighted with white dashed lines for clarity.
(TIF)
S4 Fig. GFP-PAO1 colonisation (NHBE cells). Quantitation of GFP-PAO1 on NHBE cells,
comparing cells entirely labeled with TAMRA-LL-37 vs cells with discrete punctate or no
TAMRA-LL-37 labelling. Graph shows pixel density of GFP-PAO1 staining in the green chan-
nel (measured using Photoshop CS) divided by the cell area in pixels. Data represent means
+/- SEM from n =>20 cells per condition, �� p< 0.01 by unpaired t-test.
(TIF)
S5 Fig. Timelapse series–TAMRA-LL-37 and Sytox green (NHBE cells). Timelapse series of
images taken by confocal microscopy showing NHBE cells pre-infected for 1 hour with PAO1
at 10:1 MOI and stained with 1 μg/ml Hoechst (blue) to label nuclei and 1 μM Sytox Green
(green) to detect dead cells, followed by incubation with 20 μg/ml TAMRA-LL-37 (red).
Merged and single channel (greyscale) images shown for the timepoints indicated. White
arrows identify cells where TAMRA-LL-37 labelling can be seen prior to Sytox green. Sytox
green is also seen to displace Hoechst staining on nuclei in those cells that have taken it up.
Scale bar = 50 μm.
(TIF)
S6 Fig. Effect of cathepsin B inhibition on FLICA (16HBEo- cells). FLICA Caspase 1 activa-
tion assay in 16HBE14o- cells treated for 3 hours with vehicle control (DMSO), 20 μg/ml LL-
37, PAO1 at 10:1 MOI, or PAO1 + LL-37 +/- the cathepsin B inhibitor CA-074-Me (20 μM),
recapitulating the CA-074-Me-mediated inhibition of caspase 1 activation by LL-37 in infected
cells observed in NHBE primary cells. Data represent means +/- SEM from n = 3 independent
experimental repeats, ��� p< 0.001, �� p<0.01, � p< 0.05 versus PAO1 + LL-37 + CA-074-Me
condition, by 2-way ANOVA with Bonferonni Post-test.
(TIF)
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